Showing results (431-440 of 487) with videos related to
Sort By:
Pageof 49
International Journal of Molecular Sciences|June 28, 2023
Stability Characterization of the Novel Anti-Cancer HM-10/10 HDL-Mimetic PeptideMichael P Dempsey, Katelyn E Andersen, Brittney M Wells, et al.Journal of Thrombosis and Haemostasis : JTH|October 15, 2025
Validation and clinical application of the hereditary hemorrhagic telangiectasia-specific quality of life scaleHanny Al-Samkari, Raj S Kasthuri, Vivek N Iyer, et al.Gynecologic Oncology|September 26, 2022
Clinical outcomes in patients with COVID-19 and gynecologic cancer: A society of gynecologic oncology COVID-19 and gynecologic cancer registry studyGretchen E Glaser, Olivia D Lara, Bhavana Pothuri, et al.The Lancet. Microbe|January 14, 2024
Antibiotic resistance determination using Enterococcus faecium whole-genome sequences: a diagnostic accuracy study using genotypic and phenotypic dataFrancesc Coll, Theodore Gouliouris, Beth Blane, et al.The New England Journal of Medicine|September 18, 2024
Pomalidomide for Epistaxis in Hereditary Hemorrhagic TelangiectasiaHanny Al-Samkari, Raj S Kasthuri, Vivek N Iyer, et al.Nucleic Acids Research|December 6, 2021
VID22 counteracts G-quadruplex-induced genome instabilityElena Galati, Maria C Bosio, Daniele Novarina, et al.The Plant Journal : for Cell and Molecular Biology|February 6, 2025
Boosting photosynthesis opens new opportunities for agriculture sustainability and circular economy: The BEST-CROP research and innovation actionPaolo Pesaresi, Pierre Bono, Stephane Corn, et al.Genome Biology|April 29, 2021
Complete vertebrate mitogenomes reveal widespread repeats and gene duplicationsGiulio Formenti, Arang Rhie, Jennifer Balacco, et al.Nature Genetics|March 26, 2013
The high-quality draft genome of peach (Prunus persica) identifies unique patterns of genetic diversity, domestication and genome evolution, Ignazio Verde, Albert G Abbott, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 17, 2014
Survival after neoadjuvant chemotherapy with or without bevacizumab or everolimus for HER2-negative primary breast cancer (GBG 44-GeparQuinto)†G von Minckwitz, S Loibl, M Untch, et al.Pageof 49